Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
Journal article published in 2009 by
D. Lorusso,
G. Ferrandina,
S. Pignata,
M. Ludovisi,
R. Vigano,
S. Scalone,
P. Scollo,
E. Breda,
A. Pietragalla,
G. Scambia
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 